Observational studyJAMA network open2019

Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments.

Joshua J Skydel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.